Now, he’s poised to make millions from selling them opioid - addiction. While limited information is available on the new substance, here is what i… · sackler is part of a team whose application for a patent on a new kind of buprenorphine was granted back in january. · as an executive at purdue pharma, richard sackler made billions convincing americans that oxycontin wasn’t addictive. · a member of the family that owns purdue pharma — which is being sued by more than 1,000 jurisdictions for its alleged role in seeding the opioid crisis with its pain medication oxycontin — has been. · during 2025, the knox county regional forensic center identified a new synthetic opioid in three east tennessee counties. A member of the family that owns purdue pharma — which is being sued by more than 1,000 jurisdictions for its alleged role in seeding the opioid crisis with its pain medication oxycontin — has been awarded a patent for a treatment for opioid use disorder.
